Acquis Managing Director Zach Fink joined Dr. Beatrice Anduze-Faris on “The 3 Things with Dr. B” podcast to discuss serendipity, purpose, and humanity.
In a wide-ranging conversation, Zach shared compelling perspectives on organizational transformation, personal growth, and the future of technology. Drawing from his extensive experience working with major healthcare, telecommunications, and consumer goods companies, Zach advocates for a fundamental shift in how we approach both corporate strategy and personal development.
One of Zach’s most impactful insights centers on the relationship between strategy and change. “Most companies are operating off a scorecard and list of transformations, but they’re not looking at how those transformations will work together to help them evolve as a company,” he observes. Rather than viewing transformation as discrete projects with clear endpoints, Zach argues for seeing change as continuous evolution. “We need to get away from the word transformation,” Zach shares. “It assumes a start and end – but change is constant.”
The perspectives Zach shares offer valuable insights for both organizational leaders and individuals seeking to navigate today’s rapidly changing landscape. His emphasis on coordination, continuous evolution, and authentic self-reflection provides a framework for thinking about transformation that goes beyond traditional change management approaches to embrace a more holistic and sustainable vision of progress.
Reach out to the Acquis team
Tags:
Innovation is accelerating, biotech investment is fragmenting, and market conditions are splintering under the weight of geopolitical, economic, and regulatory disruption. The companies that once defined the top of the market are no longer guaranteed to stay there. And the old playbook — great science plus patient capital equals growth — no longer works.
Read More
In the era of artificial intelligence, does private equity’s classic value creation playbook — operational improvements, margin expansion, and multiple arbitrage — still hold up?
Read More
Strategic planning often begins with a spark. Leadership teams rally around a bold vision. The room buzzes with optimism and alignment. But six months later, that energy fades. Teams scramble, timelines slip, and a familiar question resurfaces: Why isn’t our strategy working?
Read More
Innovation is accelerating, biotech investment is fragmenting, and market conditions are splintering under the weight of geopolitical, economic, and regulatory disruption. The companies that once defined the top of the market are no longer guaranteed to stay there. And the old playbook — great science plus patient capital equals growth — no longer works.
Read More
In the era of artificial intelligence, does private equity’s classic value creation playbook — operational improvements, margin expansion, and multiple arbitrage — still hold up?
Read More
Strategic planning often begins with a spark. Leadership teams rally around a bold vision. The room buzzes with optimism and alignment. But six months later, that energy fades. Teams scramble, timelines slip, and a familiar question resurfaces: Why isn’t our strategy working?
Read More
